Navigation Links
Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility
Date:10/16/2008

WORLD-RENOWNED SCIENTISTS CONVENE TO SHARE GROUNDBREAKING RESEARCH ON ALZHEIMER'S DISEASE, MEMORY AND AGING

MORGANTOWN, W.Va., Oct. 16 /PRNewswire-USNewswire/ -- Today, the new $30 million Blanchette Rockefeller Neurosciences Institute (BRNI) research headquarters located on the campus of West Virginia University and founded in honor of U.S. Senator Jay Rockefeller's mother, will play host to prominent international scientists who have achieved breakthroughs in their research on Alzheimer's disease and other memory disorders. The first-ever International Forum on Memory and Memory Disorders will highlight the work of nine celebrated scientists whose research has advanced the study of the aging brain, Alzheimer's disease, and patients suffering from memory loss and memory disorders. The Blanchette Rockefeller Neurosciences Institute is the only research institute in the world dedicated to both an understanding of how human memory works and advancing new discoveries that can identify, treat and repair damages from diseases and disorders that impact human memory.

Tomorrow, on October 17, BRNI will open its doors to the public for the official dedication ceremony of its new research facility. The approximately 78,000 square foot three-level building will provide state-of-the-art laboratory space and support research activities for 125 scientists and researchers working on the mission to find a cure for Alzheimer's disease and other memory disorders.

"This is an important moment not just for West Virginia, but for all scientists researching the diseases and disorders afflicting human memory. I know the pain felt when losing a loved one to Alzheimer's. This research will not only have an impact on the 46,000 West Virginians and their families suffering from Alzheimer's disease, but will have global significance to the 5.1 million people in the United States, and the more than 26 million people around the world who are also suffering*," said U.S
'/>"/>

SOURCE Blanchette Rockefeller Neurosciences Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
2. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
3. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
4. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
5. Amarin Signs Agreement to Acquire Ester Neurosciences
6. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
7. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. David H. Murdock Research Institute Taps Waters for Laboratory Technology
10. Dr. Larry Corey Named New Member of the Institutes of Medicine
11. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... 2010 Physicians at Thomas Jefferson University Hospital reported ... for fully automated interpretation of coronary CT angiography (cCTA) ... coronary artery disease (CAD) in the major coronary arteries ... in Chicago at the Radiological Society of North America ...
... between scientists in Donostia-San Sebastian and the University of Kiel ... determine and control the number of atoms in contact between ... same time as the electric current passing through the union ... Nanotechnology journal. One of the key problems in ...
... led by the European Science Foundation to identify the ... goes beyond space-related technologies to bring in expertise from ... and nanotechnology to energy, nuclear propulsion and robotics. ... and give scientists new tools. Yet currently space organisations ...
Cached Biology Technology:Rcadia COR Analyzer System Safely Rules Out Coronary Artery Disease in Main Coronary Arteries and Branch Vessels 2Bridging between Earth and space: technology breakthroughs for scientific progress 2
(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... with epilepsy carry might enable doctors to better predict ... suggest basic findings by researchers at the Duke University ... University College London. Patients often undergo a lengthy process ... anti-epilepsy drugs appropriate for them. , The researchers found ...
... anthropology expedition to Ethiopia's Lake Turkana basin, researchers have ... are roughly 195,000 years old. The researchers believe ... all trace to an ancient line that first evolved ... as 50,000 years ago. , Ian McDougall of Australian ...
... Professor Frank J. Slack at Yale University has identified a ... cancer, presenting new possibilities for diagnosis and treatment. The work ... Developmental Cell. , The oncogene Ras is out of control ... or activated by mutation. According to Slack, a member of ...
Cached Biology News:Gene variations explain drug dose required to control seizures 2Gene variations explain drug dose required to control seizures 3Gene variations explain drug dose required to control seizures 4New Clues Add 40,000 Years to Age of Human Species 2New Clues Add 40,000 Years to Age of Human Species 3New Clues Add 40,000 Years to Age of Human Species 4Yale Scientists Find MicroRNA Regulates Ras Cancer Gene 2
Prostaglandin E2 Luminex Standard Product Lines: Unspecified...
Rabbit polyclonal to HMGB1 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 3146 SwissProtID: P09429...
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems....
ERalpha (Ser 104/106)...
Biology Products: